Antitrust Antitrust

Indian government directed to invoke compulsory licensing for drugs to treat Covid-19 patients

By Freny Patel
  • 27 Apr 2021 04:56
  • 27 Apr 2021 04:56
As India battles a second wave of the Covid-19 pandemic and faces a shortage of life-saving drugs, the Delhi High Court has directed the government to invoke its powers of compulsory licensing under the Patent Act if all else fails.

Compulsory licensing enables a government to allow a third party to produce a

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News